Using amino acids and fatty acids to treat muscle loss in older adults

Aged and Elderly Individuals

Not applicable Interventional National Taiwan University Hospital · NCT06376266

This study is testing whether a mix of certain amino acids and fatty acids can help older adults with muscle loss feel stronger and improve their muscle mass.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment80 (estimated)
Ages50 Years and up
SexAll
SponsorNational Taiwan University Hospital Academic / other
Locations1 site (Taipei)
Trial IDNCT06376266 on ClinicalTrials.gov

What this trial studies

This clinical trial evaluates the effectiveness of a nutritional intervention combining branched-chain amino acids (BCAA) and medium-chain fatty acids (MCFA) in treating sarcopenia among middle-aged and elderly individuals. The study aims to recruit participants aged 50 and older who have been diagnosed with sarcopenia or pre-sarcopenia. By assessing the impact of these nutritional supplements on muscle mass and strength, the trial seeks to provide insights into potential strategies for reversing the effects of age-related muscle loss. The research is conducted at the National Taiwan University Hospital, focusing on a population facing significant health challenges due to aging.

Who should consider this trial

Good fit: Ideal candidates for this study are individuals aged 50 and older diagnosed with sarcopenia or pre-sarcopenia.

Not a fit: Patients who are completely dependent on activities of daily living or have a life expectancy of less than two years may not benefit from this study.

Why it matters

Potential benefit: If successful, this intervention could improve muscle mass and strength in older adults, enhancing their quality of life and reducing disability.

How similar studies have performed: Previous studies have shown promising results with nutritional interventions for sarcopenia, suggesting that this approach may be effective.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 50 years
* Diagnosis of sarcopenia or pre-sarcopenia

Exclusion Criteria:

* Lack of willingness to participate
* Complete dependence on activities of daily living
* Diagnosis of cancer
* Physician-determined life expectancy of less than two years
* Deemed incapable of undergoing assessment by a physician or clinical assessor

Where this trial is running

Taipei

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Sarcopeniabranched-chain amino acidsmedium-chain fatty acid
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.